Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

One-Way ANOVA: Equal Sample Sizes01:15

One-Way ANOVA: Equal Sample Sizes

3.4K
One-Way ANOVA can be performed on three or more samples with equal or unequal sample sizes. When one-way ANOVA is performed on two datasets with samples of equal sizes, it can be easily observed that the computed F statistic is highly sensitive to the sample mean.
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...
3.4K
One-Way ANOVA01:18

One-Way ANOVA

8.1K
One-way ANOVA analyzes more than three samples categorized by one factor. For example, it can compare the average mileage of sports bikes. Here, the data is categorized by one factor - the company. However, one-way ANOVA cannot be used to simultaneously compare the sample mean of three or more samples categorized by two factors. An example of two factors would be sports bikes from different companies driven in different terrains, such as a desert or snowy landscape. Here, two-way ANOVA is used...
8.1K
Multiple Comparison Tests01:13

Multiple Comparison Tests

4.0K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
4.0K
Test for Homogeneity01:23

Test for Homogeneity

2.1K
The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can...
2.1K
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

295
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
295
One-Way ANOVA: Unequal Sample Sizes01:15

One-Way ANOVA: Unequal Sample Sizes

5.9K
One-way ANOVA can be performed on three or more samples of unequal sizes. However, calculations get complicated when sample sizes are not always the same. So, while performing ANOVA with unequal samples size, the following equation is used:
5.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effects of silicone-based formulations on laser-induced microscopic lesions: results from a randomized trial using an in vivo human wound healing model.

Scientific reports·2026
Same author

Quality of Life After Cardiac Surgery: The QUACS Study and Benefit Prediction Model.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Transcription factor switching drives subtype-specific pancreatic cancer.

Nature genetics·2025
Same author

Longer term post-hospital morbidity and mortality following admission with COVID-19: a systematic review and meta-analysis.

ERJ open research·2025
Same author

A multidisciplinary intervention to improve postoperative antithrombotic therapy after urgent coronary artery bypass-grafts.

Annales pharmaceutiques francaises·2025
Same author

Immunomodulatory therapies in community-acquired pneumonia: a protocol for a systematic review and network meta-analysis.

BMJ open·2025
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
查看所有相关文章

相关实验视频

Updated: Sep 8, 2025

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.0K

为平均等价性测试进行多变量调整.

Younes Boulaguiem1, Luca Insolia1, Maria-Pia Victoria-Feser2

  • 1Geneva School of Economics and Management, University of Geneva, Geneva, Switzerland.

Statistics in medicine
|July 14, 2025
PubMed
概括
此摘要是机器生成的。

我们引入了一种新的统计方法,多变量alpha-TOST,以提高对多个结果的等价性测试的功率. 这种方法为制药研究提供了优越的有限样本特性.

关键词:
有限样本调整.假设测试 测试 假设测试时间间隔包括原则.多变量生物等价性两个单面试验.

更多相关视频

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
07:40

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

3.4K
Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education
09:00

Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education

Published on: August 16, 2024

907

相关实验视频

Last Updated: Sep 8, 2025

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.0K
Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
07:40

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

3.4K
Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education
09:00

Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education

Published on: August 16, 2024

907

科学领域:

  • 生物统计学 生物统计学
  • 药学指标 (Pharmacometrics) 是一个指标.
  • 统计推理 统计推理

背景情况:

  • 多变量等价性测试评估多个结果的平均值是否在两个条件之间等价.
  • 目前的方法,如多变量双单面测试 (TOST),可以随着结果和差异的增加而失去效力.
  • 这在制药研究中对于比较仿制药和品牌药物在AUC和Cmax等药理学参数方面至关重要.

研究的目的:

  • 建议对多变量等价性测试进行有限样本调整,称为多变量α-TOST.
  • 开发一种代算法,以有效计算更正的显著程度 (alpha*).
  • 为了证明多变量alpha-TOST相对于传统的多变量TOST的统一功率优势.

主要方法:

  • 建议对显著性水平 (alpha) 进行有限样本调整,考虑到结果依赖性.
  • 开发了一种代算法来确定更正的显著程度 (alpha*).
  • 运行特征在理论上和通过具有现实的条件的模拟 (小样本,未知/异质差异,各种相关性) 进行研究.

主要成果:

  • 拟议的多变量α-TOST均地比传统的多变量TOST更强大.
  • 模拟证实了优越的有限样本属性,特别是在小样本大小和复杂的相关性结构的情况下.
  • 该方法在提克罗匹丁化生物等价性案例研究中显示出更好的性能.

结论:

  • 多变量alpha-TOST提供了一种更强大,更可靠的方法,用于同时测试多个结果的等价性.
  • 该方法在实际环境中解决了传统多变量TOST的功率损失问题.
  • 这一进步对制药开发中的监管决策产生了重大影响.